FiercePharma· @FiercePharma · X·· 14 天前AI 评分42
AI 导读
BMS、小野制药就安进的Opdivo生物类似药向FDA施压，后者决定在即 https://www.fiercepharma.com/pharma/bms-ono-take-amgen-task-fdas-opdivo-biosimilar-decision-looms
正文
BMS, Ono take Amgen to task as FDA's Opdivo biosimilar decision looms https://www.fiercepharma.com/pharma/bms-ono-take-amgen-task-fdas-opdivo-biosimilar-decision-looms
来源：FiercePharma · x.com